1. Home
  2. MTZ vs ICLR Comparison

MTZ vs ICLR Comparison

Compare MTZ & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MasTec Inc.

MTZ

MasTec Inc.

N/A

Current Price

$145.63

Market Cap

15.9B

Sector

Industrials

ML Signal

N/A

Logo ICON plc

ICLR

ICON plc

N/A

Current Price

$186.25

Market Cap

13.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MTZ
ICLR
Founded
1929
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.9B
13.1B
IPO Year
2005
2001

Fundamental Metrics

Financial Performance
Metric
MTZ
ICLR
Price
$145.63
$186.25
Analyst Decision
Strong Buy
Buy
Analyst Count
22
18
Target Price
★ $301.09
$231.29
AVG Volume (30 Days)
★ 1.7M
1.1M
Earning Date
10-29-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 146.12
N/A
EPS
★ 4.32
N/A
Revenue
★ $14,299,171,000.00
N/A
Revenue This Year
$27.91
N/A
Revenue Next Year
$17.46
$4.60
P/E Ratio
$38.10
★ $12.91
Revenue Growth
★ 16.22
N/A
52 Week Low
$147.49
$66.57
52 Week High
$441.43
$219.04

Technical Indicators

Market Signals
Indicator
MTZ
ICLR
Relative Strength Index (RSI) 31.70 44.22
Support Level N/A $157.92
Resistance Level $198.23 $219.04
Average True Range (ATR) 12.15 7.29
MACD -1.38 -2.87
Stochastic Oscillator 1.83 9.14

Price Performance

Historical Comparison
MTZ
ICLR

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; pipeline infrastructure; power delivery; and other.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: